A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke.

Wolf-Rüdiger Schäbitz, Sean I Savitz

Journal: Stroke 2008;39(4):1389-91

PMID: 18309145

Abstract

Address: Department of Neurology, University of Texas, Houston Medical School, Houston, Texas, USA. [email protected]

DOI: 10.1161/STROKEAHA.107.504415

Link outs

Free resources

Medical:

https://medlineplus.gov/clinicaltrials.html

Subscription / membership required

Full Text Sources:

https://www.ahajournals.org/doi/10.1161/STROKEAHA....
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...
https://journals.lww.com/18309145.pmid

MeSH Terms: Acute Disease, Benzenesulfonates, Clinical Trials as Topic, Humans, Neuroprotective Agents, Stroke, Treatment Failure

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.